Tahlia Scheinberg

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 8

Top Venues

Asia-Pacific journal of clinical oncology

Therapeutic advances in medical oncology

Prostate cancer and prostatic diseases

Cancers

University of New South Wales (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of New South Wales

Australia

BSC

Publications

Tahlia Scheinberg, Blossom Mak, Lisa Butler, Luke Selth, Lisa G Horvath
Targeting lipid metabolism in metastatic prostate cancer. Therapeutic advances in medical oncology 15 (2023)
Alison Luk Young, Emilia Ip, Tahlia Scheinberg, Michelle Harrison, Philip Beale, Annabel Goodwin
An Australian mainstream genetic testing program: Clinicians views about current and future practices. Asia-Pacific journal of clinical oncology (2023)
Tahlia Scheinberg, Blossom Mak, Lisa Butler, Luke Selth, Lisa G Horvath
Targeting lipid metabolism in metastatic prostate cancer. Therapeutic advances in medical oncology 15 (2023)
Tahlia Scheinberg, Hui Ming Lin, Michael Fitzpatrick, Arun A Azad, Paul Bonnitcha, Amy Davies, Gillian Ziona Heller, Kevin Huynh, Blossom Mak, Kate Mahon, David Sullivan, Peter J Meikle, Lisa G Horvath
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer. Prostate cancer and prostatic diseases (2023)
Emilia Ip, Alison Luk Young, Tahlia Scheinberg, Michelle Harrison, Philip Beale, Annabel Goodwin
Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer. Asia-Pacific journal of clinical oncology 18 (5) (2022)
Blossom Mak, Hui Ming Lin, Thy Duong, Kate L Mahon, Anthony M Joshua, Martin R Stockler, Howard Gurney, Francis Parnis, Alison Zhang, Tahlia Scheinberg, Gary Wittert, Lisa M Butler, David Sullivan, Andrew J Hoy, Peter J Meikle, Lisa G Horvath
Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin. Cancers 14 (19) (2022)
Tahlia Scheinberg, Alison Young, Henry Woo, Annabel Goodwin, Kate L Mahon, Lisa G Horvath
Mainstream consent programs for genetic counseling in cancer patients: A systematic review. Asia-Pacific journal of clinical oncology 17 (3) (2020)
Tahlia Scheinberg, James Kench, Martin Stockler, Kate L Mahon, Lucille Sebastian, Phillip Stricker, Anthony M Joshua, H Woo, Ruban Thanigasalam, Nariman Ahmadi, Margaret M Centenera, Lisa M Butler, Lisa G Horvath
Pharmacodynamics effects of CDK4/6 inhibitor LEE011 (ribociclib) in high-risk, localised prostate cancer: a study protocol for a randomised controlled phase II trial (LEEP study: LEE011 in high-risk, localised Prostate cancer). BMJ open 10 (1) (2020)

Tahlia Scheinberg.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tahlia Scheinberg